Charles River Laboratories | CRL - 流动资产



金融业
股票价格
USD 300.15
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 15.57B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


流动资产 更改 日
Agilent USD 4.69B 70M 2026-06
Align Technology USD 2.66B 7.62M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Cardinal Health USD 38.75B 689M 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Cigna USD 46.99B 3.96B 2026-06
Concord Medical Services Hldg CNY 941.91M 83.42M 2025-12
CVS Health USD 75.35B 529M 2026-06
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Elevance Health USD 67.18B 152M 2026-06
Humana USD 38.08B 5.35B 2026-03
Illumina USD 2.83B 96M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.23B 6M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
McKesson USD 62.84B 5.63B 2026-06
Merck EUR 13.77B 393M 2026-06
Mettler Toledo International USD 1.35B 15.48M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
UnitedHealth USD 86.86B 4.27B 2026-06
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.9B 186M 2026-06
West Pharmaceutical Services USD 1.81B 19.3M 2026-06